Pituitary adenylate cyclase-activating polypeptide (PACAP) actions on αT3-1 gonadotrophs show desensitization

Journal of Neuroendocrinology

Volumn 9, Issue 12, 1997, Pages 893-901

  McArdle, Craig A ^a   Forrest Owen, Wyn ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adenylyl cyclase; Calcium; Desensitization; Gonadotropes; Phosphoinositidase C; Pituitary adenylate cyclase activating polypeptide; T3 1 cells

Indexed keywords

ADENYLATE CYCLASE; CALCIUM ION; CELL SURFACE RECEPTOR; CYCLIC AMP; FORSKOLIN; GONADORELIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; PHORBOL ESTER; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHODIESTERASE INHIBITOR; PROTEIN KINASE C; RECEPTOR;

ARTICLE; CALCIUM CELL LEVEL; CELL LINE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DESENSITIZATION; ENZYME ACTIVATION; GONADOTROPIN SECRETING CELL; HUMAN; HUMAN CELL; HYPOPHYSIS CELL; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM;

EID: 0031447091     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1997.00657.x     Document Type: Article

References (42)

1. Miyata A, Arimura A, Dahl RR, Minamino N, Uehara A, Jiang L, Culler MD, Coy DH. Isolation of a novel 38 residue hypothalamic peptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 1989; 164: 567-574.
2. Arimura A. Pituitary adenylate cyclase activating polypeptide (PACAP): discovery and current status of research. Reg Peps 1992; 37: 287-303.
3. Miyata A, Dahl DH, Jiang L, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A. Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 1990; 170: 643-648.
4. Arimura A. Receptors for pituitary adenylate cyclase-activating polypeptide. Comparison with vasoactive intestinal peptide receptors. Trends Endocrinol Metab 1992; 3: 288-294.
5. Gottschall PE, Tatsuno I, Arimura A. Characterization and distribution of binding sites for the hypothalamic peptide, pituitary adenylate cyclase activating polypeptide. Endocrinology 1990; 127: 272-277.
6. Pisegna JR, Wank SA. Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor. Proc Natl Acad Sci USA 1993; 90: 6345-6349.
7. Ogi K, Miyamato Y, Ciccarelli E, Stievenart M, Christophe J. Molecular cloning and functional expression of a cDNA encoding the human pituitary adenylate cyclase activating polypeptide receptor. Biochem Biophys Res Commun 1993; 196: 1511-1521.
8. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L. Differential signal transduction by five splice variants of the PACAP receptor, Nature 1993; 365: 170-175.
9. Rawlings S, Hezareh M. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP/vasoactive intestinal polypeptide receptors: actions on the anterior pituitary gland. Endocrine Revs 1996; 17: 4-29.
10. Deutsch PJ, Sun Y. The 38 amino acid form of pituitary adenylate cyclase activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem 1992; 267: 5108-5113.
11. Arimura A, Shioda S. Pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interactions. Front Neuroendocrinol 1995; 16: 53-58.
12. Arimura A, Said SI. VIP, PACAP and related peptides. Annals of the NY Acad Sci, New York: Academy of Sciences, 1996.
13. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C. Tissue distribution of PACAP as determined by RIA. Highly abundant in the rat brain and testes. Endocrinology 1991; 129: 2787-2789.
14. Dow RC, Bennie J, Fink G. Pituitary adenylate cyclase-activating peptide-38 (PACAP)-38 is released into hypophyseal portal blood in normal-male and female rat. J Endocrinol 1995; 142: R1-R4.
15. Vigh S, Arimura A, Gottschall PE, Kitada C, Somogyvari-Vigh A, Childs GW. Cytochemical characterization of anterior pituitary target cells for the neuropeptide, pituitary adenylate cyclase activating polypeptide (PACAP) using biotinylated ligands. Peptides 1991; 14: 59-65.
16. Canny BJ, Rawlings SR, Leong DA. Pituitary adenylate cyclase activating polypeptide specifically increases cytosolic calcium concentration in rat gonadotropes and somatotropes. Endocrinology 1992; 130: 211-215.
17. Culler MD, Paschall CS. Pituitary adenylate cyclase-activating polypeptide (PACAP) potentiates the gonadotropin-releasing activity of luteinizing hormone releasing hormone. Endocrinology 1992; 129: 2260-2261.
18. Tsujii T, Winters SJ. Effects of pulsatile pituitary adenylyl cyclase activating polypeptide (PACAP) on gonadotropin secretion and subunit mRNA levels in perifused rat pituitary cells. Life Sci 1995; 56: 1103-1111.
19. Tsujii T, Ishizaka K, Winters SJ. Effects of pituitary adenylate cyclase-activating polypeptide on gonadotropin secretion and subunit messenger ribonucleic acids in perifused rat pitutary cells. Endocrinology 1994; 135: 826-833.
20. McArdle CA, Counis R. GnRH, PACAP action in gonadotropes: cross-talk between phosphomositidase C and adenylyl cyclase mediated signaling pathways. Trends Endocrinol Metab 1996; 7: 168-175.
21. Schomerus E, Poch A, Bunting R, Mason WT, McArdle CA. Pituitary adenylate cyclase activating polypeptide effects in the pituitary: activation of two signal transduction pathways in the gonadotrope-derived αT3-1 cell line. Endocrinology 1993; 134: 315-323.
22. Tsujii T, Attardi B, Winters SJ. Regulation of α-subunit mRNA transcripts by pituitary adenylate cyclase-activating polypeptide (PACAP) in pituitary cell cultures and αT3-1 cells. Mol Cell Endocrinol 1995; 113: 123-130.
23. Dohlman HG, Thorner J, Caron MG, Lefkowitz RJ. Model systems for the study of seven transmembrane segment receptors. Ann Rev Biochem 1991; 60: 653-688.
24. Lefkowitz RJ, Hausdorff WP, Caron MG. Role of phosphorylation in desensitizationof the β-adrenoceptor. Trends Pharmacol Sci 1990; 11: 190-194.
25. Sibley DR, Benovic JL, Caron MG, Lefkowitz RJ. Phosphorylation of cell surface receptors: a mechanism for regulated signal transduction pathways. Endocr Revs 1988; 9: 38-56.
26. Gespach C, Emami S, Rosselin G. Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity. Biochem Biophys Res Cummun 1984; 120: 641-649.
27. Schneider H-G, Raue F, Koppold A, Ruf W, Ziegler R. Homologous desensitization of calcitonin receptors and calcitonin-dependent adenylate cyclase in T47D cells. Acta Endocrinol 1993; 128: 373-378.
28. Savage A, Zeng L, Houslay MD. A role for protein kinase C-mediated phosphorylation in eliciting glucagon desensitization in rat hepatocytes. Biochem J 1995; 307: 281-285.
29. Segre GV, Goldring SR. Receptors for secretin, calcitonin, parathyroid hormone (PTH) PTH-related peptide, vasoactive intestinal polypeptide, glucagon like peptide 1, growth hormone-releasing hormone and glucagon belong to a newly discovered G-protein linked receptor family. Trends Edocrinol Metab 1993; 4: 309-314.
30. Ozcelebi F, Holtmann MH, Rentsch RU, Rao R, Miller LJ. Agonist-stimulated phosphorylation of the carboxyl-terminal tail of the secretin receptor. Mol Pharmacol 1995; 48: 818-824.
31. Widmann C, Dolci W, Thorens B. Heterologous desensitization of the glucagon-like peptide-1 receptor by phorbol esters requires phosphorylation of the cytoplasmic tail at four different sites. J Biol Chem 1997; 271: 19957-19963.
32. Widmann C, Dulei W, Thorens B. Desensitization of the glucagon-like peptide-1 (GLP-I) receptor by GLP-1 and 4-phorbol 12 myristate 13-acetate. Mol Endocrinol 1996; 10: 62-73.
33. Pisegna JR, Wank SA. Molecular cloning and functional expression of the pituitary adenylyl cyclase-activating polypeptide Type I receptor. Proc Natl Acad Sci USA 1996; 90: 6345-6349.
34. McArdle CA, Poch A, Schomerus E, Kratzmeier M. Pituitary adenylate cyclase-activating polypeptide effects in pituitary cells: modulation by gonadotropin-releasing hormone in αT3-1 cells. Endocrinology 1994; 134: 2599-2605.
35. Post SR, Aguila-Buhain O, Insel PA. A key role for protein kinase A in homologous desenitization of the αβ2-adrenergic receptor pathway in S49 lymphoma cells. J Biol Chem 1996; 271: 895-900.
36. McArdle CA, Schomerus E, Groener I, Poch A. Estradiol regulates gonadotropin-releasing hormone receptor number, growth and inositol phosphate production in αT3-1 cells. Mol Cell Endocrinol 1992; 87: 95-103.
37. Kahn CR, Smith RJ, Chin WW. Mechanism of action of hormones that act at the cell surface. In: Wilson JD, Foster DW, eds. Williams Textbook of Endocrinology, Philadelphia: WB Saunders, 1992: 91-134.
38. Garrel G, McArdle CA, Hemmings BA, Counis R. Gonadotropin-releasing hormone and pituitary adenylyl cyclase activating polypeptide affect levels of cyclic adenosine 3′,5′-monophosphate-dependent protein kinase A (PKA) subunits in the clonal gonadotrope αT3-1 cells: evidence for cross-talk between PKA and protein kinase C pathways. Endocrinology 1997; 138: 2259-2266.
39. Windle JJ, Weiner RI, Mellon PL. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 1990; 4: 597-603.
40. Horn F, Bilezikjian LM, Perrin MH, Bosma MM, Windle JJ, Huber KS, Blount AL, Hille B, Vale W, Mellon PL. Intracellular responses to gonadotropin-releasing hormone in a clonal cell line of the gonadotrope lineage. Mol Endocrinol 1991; 5: 347-355.
41. ++ in the αT3-1, gonadotrope-derived, cell line. Mol Cell Neuroscience 1992; 3: 124-132.
42. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 340-350.